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Underlying Pathophysiology

Introduction

Today’s medical world encompasses an environment in which
gram-negative bacteria that once were defeated with common
antibiotics, have now become resistant. Gram-negative
bacteria like Klebsiella pneumoniae, Pseudomonas aeruginosa,
Enterobacter, and Acinetobacter are pathogens that are an
emerging threat causing sepsis due to multidrug-resist ance
(Pop-Vicas & Opal, 2014, p.189). The multidrug-resistance
mechanisms of gram-negative bacteria coupled with a patient
population commonly seen in hospital settings, that consist of
immunocompromised adults due to advancing age,
comorbidities (e.g. AIDS, history of transplants, diabetes, and
chemotherapy), and immunotherapies, create an environment
for advanced infection or sepsis to take place.
Complications of multidrug-resistant gram-negative bacteria
can cause infection and ultimately sepsis in the host. Sepsis is
also a very deadly condition with high morbidity and mortality
rates. Chong et al., (2015), estimated that there are
approximately 258,000 people killed in the US annually due to
sepsis with a mortality rate between 18% and 40% for those
that contract the disease (p. 111).
The topic of gram-negative bacteria and sepsis was chosen due
to the medical challenge presented to healthcare providers and
the high mortality rates associated with gram-negative
bacteria. Traditional management and treatment of sepsis
resulting from gram-negative bacteria is no longer effective and
healthcare providers are having to update and modify current
sepsis protocols to fight the infection.
•

•

•

Signs and Symptoms

Sepsis is defined as the manifestation of two or more signs
of systemic inflammatory response syndrome (SIRS) criteria
and a documented suspected infection (Palleschi, Sirianni,
O'Connor, Dunn, & Hasenau, 2014, p. 23).
SIRS is a group of symptoms/respon ses within the patient
that are activated by bacteria (gram-positive and gramnegative), viruses, fungus, and non-infectious agents like
trauma and burns. SIRS can be defined as having two or
more of the following symptoms: Body temperature higher
than 100.4 degrees Fahrenheit or lower than 96.8 degrees
Fahrenheit, heart rater greater than 90/min,
hyperventilation evidenced by respiratory rate greater than
20/min or PaCO2 lower than 32 mm Hg, and white blood cell
count greater than 12,000 cells/ uL or lower than 4,000/ uL
(Chong et al., 2015, p. 112).
In addition to meeting two or more symptoms of SIRS, the
identification of a causative or suspected
microorganism/infecti on must be identified (Sagy, Al-qaqaa,
& Kim, 2013, p. 260).

Implications for Nursing

Gram-negative bacteria contain an assortment of mechanisms that enable them to evade the
hosts immune system and become resistant to a multiple antibiotics resulting in sepsis in the
host.
Mechanism’s of evasion include: the production of extended-Beta-lactamases (ESBL) (this
enzyme inactivates a variety of antibiotics [i.e.penicillin, cephalasporins, and aztreonam],
modification of drug targets, and production of the endotoxin Lipolysaccharide (LPS) which
causes the release of pro-inflammatory mediators like macrophages, cytokines, leukotrienes, and
chemokines in the patient resulting in local inflammation vasodilation, increased capillary
permeability, clot formation and the pathogenesis of sepsis (Chong et al., 2015, p. 114).
In a septic host this response is exaggerated and adversely effects the patient. The increased
capillary permeability results in fluid shift from the intravascular space to the interstitial tissues
resulting in hypotension inadequate tissue perfusion, lactic acidosis, systemic vasodilation, and
cellular hypoxia (Dunkley & McLeod, 2015).
The hosts innate immune system continues its pro-inflammatory response by activating the
complement system and clotting cascade.
In summation, the pathogenesis of sepsis can be broken down into three mechanisms.
Mechanism 1: The pro-inflammatory response, mechanism 2: Failure of the compensatory antiinflammatory response (CARS), and mechanism 3: immunoparalysis which is the result of
inflammation overpowering the patient’s immune system paralyzing it, leading to the failure of
the immune system to neutralize pathogens (Sagy et al., 2013, p. 261).

•

•

•

•
•

•

•

•

Significance of Pathophysiology
•
•

•

Understanding the pathophysiology of gram-negative bacteria and sepsis is imperative to
successfully treat and reduce the risk of mortality of the patient.
Understanding the bodies response to severe infection causing sepsis has led to the
development of sepsis treatment bundles. Lu et al., 2015, defines sepsis treatment bundles
as a group of evidence-based interventions that provide greater benefit for the patient when
administered together as compared with any single intervention (p. 1045.)
The interventions applied in the sepsis treatment bundles are directed towards the
pathophysiology of sepsis and the course the pathogen takes in the patient’s body (i.e
reversing hypotension, glucose control to minimize optimal environment for pathogen, and
broad spectrum antibiotics due to pending blood culture results).
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Conclusion
•

•

•
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Sepsis treatment bundles require that
blood cultures are drawn to determine
the source of infection. However,
results from the cultures take up to
three days to grow and result. A nurse
practitioner’s knowledge of the high
probability of a gram-negative infection
and the prevalence of multi-drug
resistant bacteria should guide her to
the proper antibiotic treatment (PopVicas & Opal, 2014, p. 192).
With the prevalence of gram-negative
bacteria related sepsis and multi-drug
resistance, combination broadspectrum antibiotic therapy proves to
be beneficial.
Once blood culture results are obtained
the combination antibiotic treatment
can be de-escalated or limited to those
that the bacteria is responsive to (PopVicas & Opal, 2014, p. 192).

The Nurse Practitioners understanding of
the pathophysiology of sepsis and gramnegative bacteria is imperative to
successfully treat the patient and reduce
mortality.
With this high level of knowledge and
understanding, efforts to deliver
combination therapy antibiotics and
resuscitation earlier has led to new
approaches to sepsis that have shown
success (Wunderink & Walley, 2014, p. 28).
A practitioner’s knowledge of the course
of sepsis and gram-negative bacteria drug
resistance allows for rapid assessment and
can lead to practice changes to antibiotic
therapy and sepsis bundles.
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